BioPacific Ventures
Signal active
Investment Firm
Overview
BioPacificVentures concentrates on making selective investments in a small number of companies that are exceptionally innovative, have a sound business model and possess an experienced management team. Portfolio companies are actively supported by BioPacificVentures at all development stages, from R&D and clinical trial design to product launch and international expansion. Portfolio companies are uniquely positioned to leverage the deep commercial experience and strong network of industry relationships of the BioPacificVentures partners in the global nutrition, pharmaceutical, cosmetics, food and biotech areas.
Highlights
Founded
2005
Industry
Venture Capital
Employees
1-10
Investment
5
Lead Investment
1
Exits
undefined
Stages
Early Stage Venture
Investor Type
Venture Capital
Location
Oceania
Contact Information
Social
Profile Resume
BioPacific Ventures, established in 2005 and headquartered in Oceania., specializes in Early Stage Venture investments across Biotechnology, Health Care, Pharmaceutical, Medical, Therapeutics, Venture Capital, Life Science, Medical Device, Financial Services, Finance. Their recent investments include EnCoate, Ocunexus Therapeutics, Domain Associates, GBS Ventures, RMI Partners. The highest investment round they participated in was $2.6B. Among their most notable exits are EnCoate and Ocunexus Therapeutics. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
BioPacific Ventures has made 5 investments. Their most recent investment was on Nov 28, 2017, when Qool Therapeutics raised $8.0M.
investments
5
Diversity investments
0
Lead investments
1
Number of exits
undefined
Investments
5
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Apr 18, 2011 | Ocunexus Therapeutics | Biotechnology | 19.2M |
| Jul 24, 2012 | Ocunexus Therapeutics | Biotechnology | 20.0M |
| Jun 25, 2015 | Cadence Biomedical | Biotechnology | 1.2M |
| Nov 28, 2017 | Qool Therapeutics | Biotechnology | 8.0M |
Cadence Biomedical
Qool TherapeuticsExits
0
Funding Timeline
Funding rounds
5
Investors
0
Funds
1
Funding Rounds
5
BioPacific Ventures has raised 5 rounds. Their latest funding was raised on Nov 28, 2017 from a Series A - Qool Therapeutics round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Apr 18, 2011 | Series B - Ocunexus Therapeutics | - | 19.2M | - |
| Jul 24, 2012 | Series B - Ocunexus Therapeutics | - | 20.0M | - |
| Jun 25, 2015 | Series B - Cadence Biomedical | - | 1.2M | - |
| Nov 28, 2017 | Series A - Qool Therapeutics | - | 8.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.